Stockwinners Market Radar for October 30, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

21:00 EDT Deutsche Bank cuts prime lending rate by 25bps to 4.75% - Deutsche Bank announced that its New York Branch, Deutsche Bank New York, and its subsidiary Deutsche Bank Trust Company Americas have decreased their prime lending rate from 5.00% to 4.75% effective tomorrow, October 31, 2019.

20:04 EDT PG&E announces restoration of power for 196.5K customers since this morning - Pacific Gas and Electric Company confirmed that it had restored power to approximately 196,500 customers since the Oct. 29 Public Safety Power Shutoff "All Clear" was given at 10:00 a.m. today. 168,500 total PSPS impacted customers remain out of power.

19:47 EDT Citi cuts prime rate by 25bps to 4.75% - Citibank, N.A. has reduced its base lending rate to 4.75% from 5.00%, effective tomorrow, Thursday, October 31, 2019.

19:13 EDT Allakos gets orphan status for treatment of eosinophilic esophagitis - The FDA granted Allakos orphan status for its treatment of eosinophilic esophagitis. Reference Link

19:00 EDT Fly Intel: After Hours Movers - UP AFTER EARNINGS: Universal Display (OLED) up 15.2%... Moelis (MC) up 10.4%... Sprouts Farmers (SFM) up 9.3%... SunPower (SPWR) up 8.0%... Ultra Clean (UCC) up 7.7%... Murphy USA (MUSA) up 7.6%... Cirrus Logic (CRUS) up 6.9%... 8x8 (EGHT) up 5.4%... Legg Mason (LM) up 5.1%... Alphatec (ATEC) up 5.0%... Habit Restaurants (HABT) up 5.0%... Staar Surgical (STAA) up 4.9%... Facebook (FB) up 4.6%... Teladoc (TDOC) up 4.6%... Warrior Met Coal (HCC) up 4.3%... Pluralsight (PS) up 4.3%... Valaris (VAL) up 4.0%... Dynatrace (DT) up 3.7%... Zynga (ZNGA) up 3.5%... Cardtronics (CATM) up 3.5%... LendingTree (TREE) up 3.2%... Callaway Golf (ELY) up 3.2%... Qualys (QLYS) Up 3.2%... Viavi (VIAV) up 2.8%... Starbucks (SBUX) up 2.6%... Lyft (LYFT) up 1.9%... Apple (AAPL) up 1.8%... AXT Inc (AXTI) up 1.6%... Medallian Financial (MFIN) up 1.0%. ALSO HIGHER: BJs Wholesale (BJ) up 6.6% after entering S&P MidCap 400. DOWN AFTER EARNINGS: Merit Medical (MMSI) down 33.0%.... Haverty Furniture (HVT) down 11.8%... Basic Energy (BAS) down 11.3%... Western Digital (WDC) down 10.2%... Terex (TEX) down 9.1%... AK Steel (AKS) down 9.0%... Twilio (TWLO) down 8.5%... Etsy (ETSY) down 8.1%... TTM Technologies (TTMI) down 7.4%... Faro Technologies (FARO) down 7.4%... SolarWinds (SWI) down 7.0%... Lincoln Financial (LNC) down 5.0%... 3D Systems (DDD) down 4.2%... Exelixis (EXEL) down 3.6%... Perkin Elmer (PKI) down 3.1%... CF Industries (CF) down 2.9%... Conmed Corp (CNMD) down 2.6%... Cree (CREE) down 2.3%... Annaly Capital (NLY) down 2.0%... Qiagen (QGEN) down 1.9%... Bright Horizons (BFAM) down 1.9%. ALSO LOWER: Crocs (CROX) down 5.3% after equity offering... Movers as of 18:15ET.

18:39 EDT Procurant acquires SureCheck from ParTech, terms not disclosed - Procurant, a Silicon Valley technology company transforming the global food supply chain, announced a definitive agreement to acquire the SureCheck mobile food safety solutions and monitoring business from ParTech Inc., a wholly owned subsidiary of PAR Technology Corporation. "The combination of SureCheck's leading mobile food safety and task management products with Procurant's food supply chain platform creates a solution unmatched in this industry," said Eric Peters, CEO of Procurant. "With food safety and visibility across the supply chain becoming ever more critical, Procurant's innovative approach will help our customers move beyond simple homegrown systems of the past for better visibility, control and trust from farms to consumers."

18:33 EDT Suncor cuts FY19 production view to 780K-790K boe/d - Suncor has updated its production and other information in its 2019 corporate guidance, previously updated on July 24, 2019. The total production outlook range has been updated from 780,000 - 820,000 boe/d to 780,000 - 790,000 boe/d to reflect the impact of production for the first nine months of 2019 and the planned fourth quarter production given the higher levels of mandatory production curtailment. Oil Sands operations production has been updated from 410,000 - 440,000 bbls/d to 410,000 - 425,000 bbls/d, Fort Hills production has been updated from 85,000 - 95,000 bbls/d to 85,000 - 90,000 bbls/d, and E&P production has been updated from 105,000 - 115,000 boe/d to 105,000 - 110,000 boe/d. As a result of the changes to the Oil Sands operations production range, the SCO sales range has narrowed from 315,000 - 335,000 bbls/d to 315,000 - 320,000 bbls/d. Oil Sands operations cash operating costs per barrel have been updated to $27.00 - $28.00 from $24.00 - $26.50, reflecting mandatory production curtailment, the impact of conscious decisions taken to change the production mix to maximize the value of the barrels while operating under curtailment, and higher maintenance and contractor costs. East Coast Canada royalties have been updated from 17% - 21% to 13% - 17%, with the decrease in royalty rates attributed to the change in production mix among the company's East Coast assets. Suncor has also updated its full year business environment outlook assumptions for Brent Sullom Voe from US$66.00/bbl to US$63.00/bbl, WTI at Cushing from US$58.00/bbl to US$56.00/bbl, AECO - C Spot from $1.70/GJ to $1.50/GJ, New York Harbor 2-1-1 crack from US$19.00/bbl to US$20.00/bbl, and the Cdn$/US$ exchange rate from 0.76 to 0.75, due to changes in key forward curve pricing for the remainder of the year.

18:22 EDT Wingstop CEO: We have all the right sales drivers in place - In an interview on CNBC's Mad Money, Wingstop CEO Charles Morrison said: We have a runway for growth not only here in the U.S. but in the whole world... We are very bullish on our partnership with DoorDash... Delivery is a perfect fit for us.

18:16 EDT Great Panther Silver CEO James Bannantine departs, Jeff Mason named interim CEO - Great Panther Silver announces that James Bannantine, President & CEO, has departed the company effective October 30 following a determination by the company's Board of Directors to effect a leadership change. Board Chair, Jeffrey Mason, has assumed the additional role of Interim President & CEO and will continue in that capacity until a permanent successor is in place. Mason has been actively involved in overseeing the company's operations since his appointment as Board Chair in July. Mason first joined Great Panther's Board in May 2014 and has played an active role on various committees developing the strategic direction of the company and overseeing acquisitions and integration. A formal search process is being commenced forthwith.

18:06 EDT Webster Financial lowers prime lending rate to 4.75% from 5% - Webster Financial announced that it has lowered its prime lending rate to 4.75% from 5% effective October 31.

18:04 EDT Innovative Industrial Properties closes $10.5M leaseback deal with GR Companies - Innovative Industrial Properties announced that it closed on a sale-leaseback transaction with a subsidiary of GR Companies Inc. for a property located in Litchfield, Illinois, which comprises approximately 70,000 square feet of industrial space. The purchase price for the property was $10.5M. Concurrent with the closing of the acquisition, IIP entered into a long-term, triple-net lease agreement for the property with Grassroots, which intends to continue to operate the property as a licensed cannabis cultivation and processing facility. Grassroots is also expected to complete additional tenant improvements for the property, including a 50,000-square-foot planned expansion, for which IIP has agreed to provide reimbursement of up to approximately $17.7M, which funding is subject to reduction at Grassroots' option within the first nine months of the lease term. Assuming full reimbursement for the tenant improvements, IIP's total investment in the property will be approximately $28.2M.

18:00 EDT Apple says Q4 third party subscriptions grew 40% y/y - Says: Half of iPad purchasers were new to iPad... Saw five times iPhone trade in volume vs. last year... Giving TV+ to iPhone users is a "gift"... About 75% of Apple Watch buyers are new to Apple Watch... Trade tensions are less, looking more positive... Wearables are doing "so great" in China... Saw key gaming approvals in China in Q4... Expects better China reception as trade tensions wane... Paying some tariffs currently... Tone has changed significantly on tariffs... FX "clearly a headwind for us right now"... Committed to making monthly hardware payments easier... Too early to tell Apple Arcade conversion rate... Apple Arcade off to good start.

17:52 EDT U.S. Bancorp cuts prime lending rate by 25bps to 4.75% - U.S. Bancorp has decreased its prime lending rate to 4.75% from 5.00%, effective tomorrow, October 31, 2019, at all U.S. Bank locations.

17:39 EDT Tidewater names Larry T. Rigdon chairman of the board - Tidewater announced that Larry T. Rigdon has been elected Chairman of the Board of Tidewater Inc. effective October 28. Rigdon replaces Dr. Thomas R. Bates, Jr., who has recently resigned from the board. Rigdon has been a member of the Tidewater Board of Directors since August 2017. He has extensive prior experience as an executive at Tidewater. Rigdon served as Interim Chief Executive Officer of Tidewater for the five-month period ended March 2018 and had previously joined the company in 1992 upon the merger with Zapata Gulf Marine Corporation. Additionally, the Company announces that the size of the board has been reduced from ten to eight members effective immediately. The immediate reduction in board size is the result of the resignation of Dr. Thomas R. Bates, Jr. and Mr. Steven L. Newman. These resignations were not the result of any known disagreements between the resigning directors and management or the board of Tidewater. In connection with these changes, the board has appointed, effective immediately, Ms. Randee E. Day to be Chairwoman of the Nominating & Governance Committee, Mr. Louis A. Raspino to be Chairman of the Compensation Committee, and has confirmed Mr. Dick H. Fagerstal as Chairman of the Audit Committee.

17:36 EDT Starbucks foresees minimal impact from foreign currency translation in FY20 - Sees higher FY20 interest cost as a result of debt issuances. Says foresees minimal impact from foreign currency in FY20. Sees favorable coffee costs, higher dairy costs in FY20. Sees year-over-year EPS growth at its highest in Q4 for FY20.

17:35 EDT Covetrus to replace Assertio Therapeutics in S&P 600 at open on 11/5 - Assertio Therapeutics is ranked near the bottom of the S&P SmallCap 600 and is no longer representative of the small-cap market space.

17:33 EDT Oceaneering to replace Tile Shop in S&P 600 at open on 11/5 - Tile Shop Holdings announced that it is voluntarily delisting its common shares from NASDAQ and will no longer trade on an eligible exchange.

17:32 EDT Ceridian to replace Oceaneering in S&P 400 at open on 11/5 - Oceaneering International has a market capitalization that is more representative of the small-cap market space.

17:31 EDT Starbucks 'fully committed' to long-term model of double-digit EPS growth - Says remains "fully committed" to long-term model of double-digit EPS growth. Sees sequential improvement in net new stores in FY20.

17:27 EDT General Dynamics awarded $162.4M Army procurement contract - General Dynamics was awarded a $162.4M hybrid contract to procure small multipurpose equipment transport systems; support hardware including authorized stockage list kits and prescribed load list kits and services for refurbishment, user training, field service representative, system technical support, program management support for pre-production meetings, and storage. Four bids were solicited with four received. Work locations and funding will be determined with each order, with an estimated completion date of October 29, 2024. U.S. Army Contracting Command is the contracting activity.

17:24 EDT ICL signs contract for sale of Potash to customer in India - ICL announced that further to its announcement regarding a five-year supply agreement with Indian Potash Limited, India's largest importer of potash, the company signed an agreement to update the price by $10 less per tonne, for all shipments from October 2019 to March 2020.

17:19 EDT Apple says saw improvement in revenue trends in China in Q4 - Says: Set Q4 records for Wearables...Saw amazing Wearable results for airpods, watch, beats... iPhone 11 is best selling phone... Saw double-digit services growth globally... New all-time highs for App store, Music... Well on way to double FY16 services revenue in 2020... All time record revenues on payment services... Apple Pay transactions doubled y/y... Apple Pay in 49 markets, 6,000 issuers..."Thrilled by positive reception" to Apple Card.. To launch no interest iPhone payments on Apple Card... To let users manage iPhone payments on Apple Card...Crossed $100B in U.S. revenue for first time in FY19... "Enormous amount" to look forward to over holidays. Comments taken from Q4 earnings conference call.

17:18 EDT Starbucks says made 'significant strides' expanding digital footprint in China - Says has "strong evidence" approach to traffic and customer experience is working. Says making targeted investments in partnerships to improve customer experience. Says has made "significant strides" expanding digital footprint in China. Says surpassed goal to expand Starbucks Delivers in China. Says FY19 gives company confidence in growth strategies. Says has made significant progress to streamline company. Says "excited" about ability to sustain growth heading into FY20. Comments taken from Q4 earnings conference call.

17:16 EDT Facebook CEO says Payments is area he is 'most excited about' - Says being able to send money as easily as sending a photo can open up more opportunities for businesses. Says will work with regulators to address all concerns before Libra can be launched. Says the launched Oculus Quest has gotten good reviews, shipping the product "as fast as we can make them". Expect to see even more innovation in augmented and virtual reality in the next few years. Says this technology will be among the company's most important contributions. Says Q3 is an "important quarter" because we now "have a path forward". Comments taken from Q3 earnings conference call.

17:14 EDT HSBC Bank USA cut prime, reference rates to 4.75%-5% - HSBC Bank USA, N.A., and its affiliates announced that they have lowered their prime and reference rates to 4.75% from 5.00%, effective Oct. 31, 2019.

17:09 EDT TherapeuticsMD, Knight Therapeutics file NDS for Joyesta in Canada - Knight Therapeutics and TherapeuticsMD announced that Knight's New Drug Submission, or NDS, for Joyesta has been accepted for review by Health Canada. Joyesta, licensed from TherapeuticsMD, is an applicator-free estradiol softgel vaginal capsule for the treatment of postmenopausal symptoms of vulvar and vaginal atrophy due to estrogen deficiency. Joyesta is marketed as IMVEXXY by TherapeuticsMD in the U.S., for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.

17:06 EDT Citizens Financial cuts prime lending rate to 4.75% from 5% - Citizens Financial announced that Citizens Bank, N.A. has lowered its prime lending rate to 4.75 percent from 5.00 percent, effective Thursday, October 31, 2019.

17:04 EDT Legg Mason reports AAUM $781.8B at September 30 - Compared with $780.2B at June 30. The change resulted from positive market performance and other of $8.7B, partially offset by liquidity outflows of $3.5B, negative foreign exchange of $3.2B, long-term net outflows of $0.2B and realizations of $0.2B.

17:00 EDT Wells Fargo cuts prime rate to 4.75% from 5% - Wells Fargo Bank, N.A., said it is decreasing its prime rate to 4.75 percent from 5.00 percent, effective tomorrow, Oct. 31, 2019.

16:59 EDT Northern Trust cuts prime rate to 4.75% from 5% - The Northern Trust Company has decreased its prime rate from 5.00% to 4.75%, effective Thursday, October 31, 2019.

16:52 EDT PerkinElmer acquires Meizheng Group, terms not disclosed - PerkinElmer announced the recent acquisition of Meizheng Group, a food safety testing company in China. The addition of Meizheng expands PerkinElmer's food safety capabilities into attractive markets, including pathogen, toxin, and drug residue testing.

16:50 EDT TCF Financial cuts prime rate to 4.75% from 5% - TCF Financial Corporation and its subsidiaries announced today that they are lowering their prime rate to 4.75 percent from 5.00 percent, effective tomorrow, October 31, 2019.

16:49 EDT Lincoln National raises quarterly dividend 8% to 40c per share - The board of directors of Lincoln National Corporation approved raising the quarterly dividend on its common shares to $0.40 per share. The dividend represents an 8% increase over the prior-year level. The increased dividend on common stock will be payable on February 1, 2020 to shareholders of record at the close of business on January 10, 2020.

16:46 EDT Churchill Downs announces $11M investment at Churchill Downs Racetrack - Churchill Downs announced that it will invest $11M to create a premium upscale experience on the 6th floor next to The Mansion at Churchill Downs Racetrack - the home of The Kentucky Derby. The newly renovated area with views of the racetrack's finish line will replace the existing Millionaires Row on level 6 in time for guests at the 2020 Kentucky Derby. Renovation will begin in December 2019 and will be completed prior to the running of the 146th Kentucky Derby on Saturday, May 2, 2020.

16:45 EDT KeyCorp lowers prime lending rate to 4.75% from 5%, effective October 31

16:44 EDT Associated Banc-Corp lowers prime rate to 4.75% from 5% - Associated Banc-Corp announced it has decreased the bank's prime rate from 5% to 4.75%, effective October 31.

16:42 EDT Continental Resources sees FY19 average oil production 195,000-200,000 Bopd - Sees FY19 average natural gas production 820,000-840,000 Mcfpd.

16:40 EDT Churchill Downs joint venture announces $100M expansion - Churchill Downs (CHDN) announced that Miami Valley Gaming & Racing, its joint venture racino with Delaware North Gaming & Entertainment, plans to build a hotel, parking garage and expanded gaming floor and add up to 250 additional video lottery terminals. The $100M expansion is scheduled to be completed by Q2 of 2021 and will be financed with debt at the joint venture. The proposed project will include 192 rooms and suites, a new full-service restaurant, coffee bar and 1,000-car parking garage, which will allow MVG to expand the geographical market reach of the property. The expansion will add over 10,000 square feet of gaming floor space and increase the number of VLTs in operation to approximately 2,200.

16:38 EDT Tandem Diabetes presents 'positive' data from pediatric users of t:slim X2 - Tandem Diabetes announced presentation of real-world data from pediatric users of the t:slim X2 insulin pump with Basal-IQ(R) predictive low-glucose suspend technology at the 45th annual conference of the International Society for Pediatric and Adolescent Diabetes. Data from 2,696 users under the age of 18 years old showed an overall rate of hypoglycemia of only 0.9% when using Basal-IQ technology. A subgroup of users with at least 21 days of sensor-augmented pump data prior to use of Basal-IQ technology demonstrated a 31% reduction in hypoglycemia following introduction of the feature.

16:36 EDT Apple shares jump 2% to $248.99 following fiscal Q4 results

16:35 EDT TTM Technologies trading resumes

16:34 EDT Amalgamated Bank increases quarterly dividend 33% - Amalgamated Bank announced that its board has declared a regular dividend to common shareholders of 8c per share, a 33% increase from the previous quarterly dividend of 6c per share. The dividend is payable on November 29 to shareholders of record on November 15.

16:33 EDT Lyft down 1.4% after reporting Q3 earnings, updating FY19 guidance

16:31 EDT Apple declares quarterly dividend of 77c per share - Apple's board of directors has declared a cash dividend of 77c per share of the company's common stock. The dividend is payable on November 14, to shareholders of record as of the close of business on November 11.

16:28 EDT Alexander & Baldwin sees FY19 same-store cash NOI up 4.5%-5.5% - Sees 2019 comparable leasing apreads within a range of 5.5%-6.5%, maintenance Cap. Ex. expected to be $11M, growth cap. ex. projected at $30M, total Acquisitions in 2019 of $220M.

16:24 EDT MasterCraft Boat Holdings appoints Frederick Brightbill interim CEO - MasterCraft Boat Holdings announced that its board has appointed current board chair, Frederick Brightbill, as interim CEO, effective immediately. Brightbill's appointment follows Terry McNew's decision to step down as president, CEO and a director of the company to pursue an opportunity outside of the boating industry. Brightbill is expected to serve until the company completes a search and appoints a new CEO.

16:23 EDT Facebook up 3% in after-hours trading following earnings beat - At time of writing, Facebook shares are up $5.11, or 2.7%, to $193.36.

16:22 EDT Etsy narrows FY19 adjusted EBITDA margin to 22%-23% from 22%-24% - The company said, "We expect Reverb will contribute approximately 5-6% to GMS growth and 2-3% to revenue growth, and will contract Adjusted EBITDA margins as we align Reverb with Etsy's benefit programs and capitalization guidelines for internal development."

16:21 EDT Western Digital CEO Steve Milligan to retire - Western Digital announced that Steve Milligan, CEO and a member of the Western Digital Board of Directors since January 2013, has informed the Board that he intends to retire as the Company's CEO. Milligan will continue to serve as CEO until the Board has identified and appointed a successor, and then will remain with the Company in an advisory role until September 2020 to ensure a smooth transition. He will also remain a director on the Company's Board for a transition period after his successor is appointed. The Board has initiated a search to identify Western Digital's next CEO, and has engaged Heidrick & Struggles, a leading executive search firm, to assist in the process. In order to facilitate a comprehensive process, the Board will evaluate both internal and external candidates.

16:18 EDT MGM Resorts CFO says focused on achieving 2020 targets - "We remain focused on achieving our 2020 targets of $3.6B-$3.9B in consolidated Adjusted EBITDA and significant growth in free cash flow per share," said Corey Sanders, CFO and Treasurer of MGM Resorts. "The key drivers remain the benefits of our MGM 2020 plan, which is currently tracking ahead of expectations; healthy market conditions in Las Vegas and regional markets; and the ongoing ramp up of newly opened properties, especially MGM Cotai. We are also targeting consolidated net financial leverage of 3-4x and approximately 1x net domestic financial leverage - excluding MGP - by the end of 2020."

16:11 EDT Twitter to stop all political advertising globally, CEO says - Twitter CEO Jack Dorsey tweeted: "We've made the decision to stop all political advertising on Twitter globally. We believe political message reach should be earned, not bought. Why? A few reasons... A political message earns reach when people decide to follow an account or retweet. Paying for reach removes that decision, forcing highly optimized and targeted political messages on people. We believe this decision should not be compromised by money... While internet advertising is incredibly powerful and very effective for commercial advertisers, that power brings significant risks to politics, where it can be used to influence votes to affect the lives of millions... Internet political ads present entirely new challenges to civic discourse: machine learning-based optimization of messaging and micro-targeting, unchecked misleading information, and deep fakes. All at increasing velocity, sophistication, and overwhelming scale." Reference Link

16:11 EDT Entasis Therapeutics appoints David Altarac as Chief Medical Officer - Entasis Therapeutics Holdings announced the appointment of David Altarac, M.D. as Chief Medical Officer, effective November 4. In conjunction, Robin Isaacs, M.D., who has served as the company's Chief Medical Officer since July 2015, announced his plans to retire at the end of 2019. Dr. Isaacs will continue as an advisor to the company as the Phase 3 programs move toward regulatory review.

16:10 EDT Starbucks reports active U.S. rewards members up 15% to 17.6M

16:09 EDT Facebook estimates around 2.2B people use family of services daily - Facebook estimates that around 2.2B people now use Facebook, Instagram, WhatsApp, or Messenger every day on average, and around 2.8B people use at least one of our Family of services each month.

16:08 EDT Sprouts Farmers Market sees Q4 comparable store sales growth 0%-1%

16:06 EDT Sprouts Farmers Market reports Q3 comparable store sales growth of 1.5%

16:00 EDT TTM Technologies trading halted, news pending

15:30 EDT M&T Bank cuts prime lending rate to 4.75% from 5% - Effective Thursday, October 31, 2019, M&T Bank will decrease its prime lending rate from 5.00% to 4.75%.

14:40 EDT National Storage trading resumes

14:19 EDT Trump thanks GM, FCA, Toyota over CA emissions dispute - U.S. President Donald Trump on Twitter thanked General Motors (GM), Fiat Chrysler (FCAU), Toyota (TM), and Global Automakers for standing with the U.S. government for "Better, Cheaper, Safer Cars for Americans. California has treated the Auto Industry very poorly for many years, harming Workers and Consumers. We are fixing this problem!" Reference Link

14:09 EDT ICU Medical issues recall of single lots of Lactated Ringer's, Sodium Chloride - ICU Medical (ICUI) is voluntarily recalling one single lot of Lactated Ringer's Injection, USP, and one single lot of 0.9% Sodium Chloride Injection, USP. The products are being recalled to the hospital level due to the presence of particulate matter. The affected product lots were manufactured in the U.S. for ICU Medical by Hospira, a Pfizer (PFE) company, in late 2017 and early 2018, ICU stated. ICU Medical is notifying its distributors and customers of this recall by letter and is arranging for the return of all recalled products. Hospitals/distributors that have product that is being recalled should stop use/further distribution and return to place of purchase.

13:49 EDT National Storage trading halted, news pending

13:34 EDT PG&E says issued weather 'all clear' for most areas impacted by PSPS - Pacific Gas and Electric Company confirmed that it issued a weather "all clear" for nearly all of the areas impacted by the Oct. 29 Public Safety Power Shutoff, which means winds had subsided to safe levels to allow crews to begin safety inspections of de-energized equipment, repair any wind damage, and restore power. Kern County is expected to be "all clear" for inspections on Thursday morning, given continued significant wind activity in the southern part of PG&E's service area. In addition, inspection and restoration work continues this morning for customers impacted by the larger Oct. 26 PSPS. The PSPS event that began Oct. 26 impacted 973,000 customers in portions of 38 counties. The more recent PSPS event on Oct. 29 impacted 516,000 customers in portions of 22 counties -- includes approximately 400,000 customers from the Oct. 26 PSPS event. From the two most recent PSPS events, approximately 365,000 customers remain out of power while 723,000 customers have been restored as of 10:00 a.m. "We very much appreciate our customers' patience as we work to restore electric service safely and as quickly as possible. We recognize the disruption and hardship these shutoffs cause, especially when they happen in quick succession due to the current weather pattern. However, we only execute Public Safety Power Shutoffs in the interest of preventing catastrophic wildfires and protecting public safety, given the severe winds and bone-dry conditions in more and more of our communities," said Michael Lewis, Senior Vice President for Electric Operations, PG&E.

13:33 EDT PG&E says issued weather 'all clearly' for most areas impacted by PSPS - Pacific Gas and Electric Company confirmed that it issued a weather "all clear" for nearly all of the areas impacted by the Oct. 29 Public Safety Power Shutoff, which means winds had subsided to safe levels to allow crews to begin safety inspections of de-energized equipment, repair any wind damage, and restore power. Kern County is expected to be "all clear" for inspections on Thursday morning, given continued significant wind activity in the southern part of PG&E's service area. In addition, inspection and restoration work continues this morning for customers impacted by the larger Oct. 26 PSPS. The PSPS event that began Oct. 26 impacted 973,000 customers in portions of 38 counties. The more recent PSPS event on Oct. 29 impacted 516,000 customers in portions of 22 counties -- includes approximately 400,000 customers from the Oct. 26 PSPS event. From the two most recent PSPS events, approximately 365,000 customers remain out of power while 723,000 customers have been restored as of 10:00 a.m. "We very much appreciate our customers' patience as we work to restore electric service safely and as quickly as possible. We recognize the disruption and hardship these shutoffs cause, especially when they happen in quick succession due to the current weather pattern. However, we only execute Public Safety Power Shutoffs in the interest of preventing catastrophic wildfires and protecting public safety, given the severe winds and bone-dry conditions in more and more of our communities," said Michael Lewis, Senior Vice President for Electric Operations, PG&E.

13:07 EDT Rockwell Automation increases quarterly dividend 5% - The board of Rockwell Automation, following its regular quarterly review, declared a quarterly dividend of $1.02 per share on its outstanding common stock, payable December 10 to shareowners of record at the close of business on November 12. "The 5% increase reflects our confidence in Rockwell Automation's ability to generate cash throughout the cycle and our commitment to returning cash to shareowners while investing in our business," said Rockwell Automation CEO Blake Moret.

12:28 EDT General Motors says President Mark Reuss takes on additional leadership role - General Motors announced a series of executive appointments, effective Nov. 1, 2019. Mark Reuss, who was named company president in January 2019, expands his role and will oversee the company's regions: North America, South America, China and International. He continues to report to Chairman and CEO Mary Barra. Doug Parks, vice president of Autonomous and Electric Vehicle Programs, is promoted to the role of executive vice president, Global Product Development, Purchasing and Supply Chain. He will report to Reuss and join the company's Senior Leadership Team. Steve Kiefer, senior vice president, Global Purchasing and Supply Chain, is named senior vice president and president, GM South America and International Operations, reporting to Reuss. Carlos Zarlenga, president and managing director, GM South America, and Julian Blissett, senior vice president, International Operations, will report to Kiefer. "Our industry is transforming faster than at any time in its history," said Barra. "Aligning our regional operations under Mark will drive even greater collaboration and speed-to-market, and accelerate growth opportunities in our core business and in the future of mobility."

12:11 EDT Viacom, CBS announce ViacomCBS leadership for lines of revenue - CBS (CBS) and Viacom (VIAB) announced senior leadership appointments across ViacomCBS' revenue lines. The appointments, effective upon closing of the deal to combine CBS and Viacom, will enable ViacomCBS to drive strong, multifaceted opportunities with distributors, advertisers and other partners. Jo Ann Ross, President and Chief Advertising Revenue Officer, CBS, will serve as President and Chief Advertising Revenue Officer, ViacomCBS Domestic Advertising Sales. Ross will direct all of ViacomCBS' multiplatform media sales efforts. John Halley, Executive Vice President and COO, Ad Solutions, Viacom, will serve as Chief Operating Officer, Advertising Revenue, and Executive Vice President, Advanced Marketing Solutions, reporting to Ross. Ray Hopkins, President of Television Networks Distribution, CBS, will serve as President, U.S. Network Distribution, ViacomCBS, overseeing the combined company's broadcast network affiliation distribution agreements, as well as domestic distribution of the company's owned and operated television stations, channels and networks across all platforms. Armando Nunez, President and CEO, CBS Global Distribution Group, and Chief Content Licensing Officer, CBS, will serve as Chairman, Global Distribution and Chief Content Licensing Officer, ViacomCBS, overseeing all content licensing, including worldwide distribution and domestic syndication, for ViacomCBS-owned programming to third-party platforms. Dan Cohen, President of Worldwide Home Entertainment & Television Distribution, Paramount, will serve as President, Global Content Licensing, ViacomCBS, reporting to Nunez. Pam Kaufman, President, Viacom/Nickelodeon Global Consumer Products, will serve as President, Global Consumer Products, ViacomCBS. David Lynn, President and CEO of Viacom International Media Networks, will oversee the combined company's international media networks, including Network 10 in Australia. The merger remains subject to customary closing conditions and is expected to close by early December.

12:03 EDT Apple launches water resistant noise-cancelling earbuds - Apple said in an earlier statement: "AirPods Pro went on sale on Wednesday, October 30, around the world. AirPods Pro join the AirPods family and feature Active Noise Cancellation, Transparency mode, sweat and water resistance, and superior, immersive sound, in an all-new lightweight, in-ear design." Reference Link

12:01 EDT Mayville Engineering falls -22.9% - Mayville Engineering is down -22.9%, or -$2.69 to $9.07.

12:01 EDT Quad/Graphics falls -51.9% - Quad/Graphics is down -51.9%, or -$5.84 to $5.42.

12:00 EDT Inphi rises 17.4% - Inphi is up 17.4%, or $10.33 to $69.77.

11:56 EDT Microsoft confirms Xbox Console Streaming program - Microsoft is allowing Xbox One beta testers to stream games from their console to an Android phone or tablet. Jonathan Hildebrandt, Principal Program Manager at Microsoft noted in a blog post yesterday: "Test out our newest Xbox One console feature...oday, we at Team Xbox are excited to talk about Xbox Console Streaming, our new system feature that lets you play your Xbox One games from your console on a mobile device. If you're an Xbox Insider in the Alpha and Alpha Skip-Ahead rings in the US and UK, you can now try a preview of Xbox Console Streaming. You'll be able to play your owned and installed Xbox One games, including Xbox Game Pass titles, on an Android phone or tablet remotely from your home console. Our vision at Xbox is to empower you to play Xbox games where you want, when you want. Whether you've got just a few minutes to complete a race in Forza, or find yourself with an hour to get some online multiplayer in before the next train arrives, console streaming allows you to play your games on the go." Reference Link

11:40 EDT Molson Coors says plans to launch hard seltzer early next year - Comments taken from Q3 earnings conference call. The Fly notes that Boston Beer is also planning to launch Truly hard seltzer.

10:34 EDT Green Dot to issue Walmart 975,000 restricted shares as part of agreements - As reported last night, Walmart (WMT) and Green Dot (GDOT) announced that the companies have entered into two new and distinct agreements. First, Walmart and Green Dot have entered into an agreement whereby Green Dot will continue to serve as the issuing bank and program manager for the Walmart MoneyCard program for an additional period of seven years. Additionally, Walmart and Green Dot have agreed to jointly establish a new fintech accelerator under the name "TailFin Labs." In a regulatory filing related to the agreements, Green Dot disclosed that "in recognition of the many different lines of business in which Walmart and Green Dot are engaged, inclusive of the new agreements announced today, the company agreed to issue to Walmart, in a private placement, 975,000 restricted shares of the company's Class A Common Stock to serve as an incentive for the parties to work together to achieve growth across all of their current and future mutual lines of business. The issuance will occur on January 2, 2020, and the Walmart Shares will vest in equal monthly increments between January 2, 2020 and December 1, 2022. Walmart will be entitled to vote and receive dividends paid on the Walmart Shares from the issuance date. Walmart has agreed to vote the Walmart Shares in the manner recommended by the company's board of directors to the company's stockholders generally."

10:17 EDT Magna awarded DOE grant to develop, 'auto-qualify' electric motor technologies - Magna has been awarded a grant by the U.S. Department of Energy to develop and 'auto-qualify' advanced electric motor technologies for next-generation vehicle propulsion systems. In partnership with the Illinois Institute of Technology and University of Wisconsin-Madison, Magna is applying its powertrain, electronics and full-vehicle expertise to deliver an automotive-grade, high-performance electric motor that aims to achieve increased power density and reduced cost compared to current e-motors. The project objective is to develop an electric motor that is half the cost and eight times the power density, while delivering 125 kW of peak power - similar to packing a gallon of milk into a pint-size container. The reduction in cost is the result of eliminating the use of rare-earth permanent magnets, which make up a significant portion of electric-motor cost.The project will integrate the exclusive electric motor technologies with a transmission and inverter as part of an overall e-drive system. The project scope includes development and use of innovative materials, cooling technologies, winding technologies, simulation models, as well as control and optimization techniques. Designing for automotive standards and low-cost manufacturing using Magna's comprehensive design framework is another key element of the project. The electric motor technologies will be presented to U.S. DOE for evaluation in 2021.

10:16 EDT BAE Systems awarded $120M contract from U.S. Marine Corps - BAE Systems has received a $120M contract from the U.S. Marine Corps for additional Amphibious Combat Vehicles under a third order for Low Rate Initial Production. This latest contract is for the ACV personnel carrier variant, an eight-wheeled amphibious assault vehicle capable of transporting Marines from open-ocean ship to shore and conducting land operations. Each vehicle embarks 13 Marines in addition to a crew of three. Current low-rate production is focused on the ACV-P variant. More variants will be added under full rate production to include the command and control, 30mm medium caliber turret and recovery variants under the ACV Family of Vehicles program. BAE Systems previously received the Lot 1 and Lot 2 awards.

10:01 EDT Hibbett Sports launches same-day delivery in four regional markets - Hibbett Sporting Goods announced same-day delivery via Shipt as the latest enhancement to the www.Hibbett.com shopping experience. The new same-day delivery service allows Hibbett customers to select from thousands of apparel and footwear items to purchase and receive on the same day. Available in several markets including; Atlanta, Birmingham, Charlotte and select Nashville area zip codes.

10:00 EDT Tupperware Brands falls -28.4% - Tupperware Brands is down -28.4%, or -$4.41 to $11.13.

10:00 EDT Inphi rises 16.4% - Inphi is up 16.4%, or $9.72 to $69.16.

10:00 EDT Antero Resources rises 18.0% - Antero Resources is up 18.0%, or 51c to $3.35.

09:48 EDT MGIC Investment vice chairman sells $2.4M of shares - MGIC Investment vice chairman Patrick Sinks disclosed the sale of 160,236 shares at prices of $14.02 and $13.96. Sinks, whose sales total $2.24M, continues to own 1.97M shares of MGIC Investment.

09:47 EDT Tupperware Brands falls -20.2% - Tupperware Brands is down -20.2%, or -$3.15 to $12.39.

09:47 EDT Anixter rises 14.4% - Anixter is up 14.4%, or $10.28 to $81.67.

09:47 EDT Green Dot rises 29.7% - Green Dot is up 29.7%, or $7.65 to $33.41.

09:38 EDT Driver says First United shareholders could receive $26-$33 per share in a sale - Driver Management Company, the manager of a fund that holds more than 5% of the outstanding shares of First United Corporation issued a statement to accompany its presentation focused on First United's. The presentation-"First United: Still No Strategy"-can be downloaded and viewed at www.RenovateMyBank.com. Abbott Cooper, Driver's founder and managing member, commented: "Driver has outlined an extremely appealing and logical path to maximizing value for First United's shareholders: we believe there are a number of potential high-quality buyers for First United, shareholders could receive between $26 and $33 per share in a sale, and a transaction can be achieved quickly with minimal execution risk. We have suggested to First United's Board of Directors that if it is unwilling to act in the best interests of shareholders right now and run a sale process, it should demonstrate how the Company could produce sale-level value on a standalone basis. Other major investors have also asked First United to either run a sale process or show why remaining independent is a better alternative. With the release of its unconvincing and misrepresentative investor presentation last week, we believe First United's leadership has made clear that remaining independent would be a dismal path forward for shareholders, customers, and many employees. Despite wasting months on a strategic plan intended to demonstrate how First United could potentially earn its independence, the Company has produced a presentation that insults shareholders by offering no tangible roadmap for maximizing value. I mean nothing-as in nada, zero, zilch. Fortunately, it is not too late for First United to wake up to the overwhelming demand amongst shareholders for a sale. Driver remains willing to present its ideas and recommendations to the Board of Directors for how a value-maximizing sales process can be expeditiously run. If the status quo remains, however, we will have no choice but to nominate a slate of highly-qualified director nominees to bring the right independent perspectives to a boardroom that is desperately in need of a renovation."

09:33 EDT Internet Gold appeals Nasdaq delisting notice - As disclosed on October 24, 2019, the Company received written notification from the Listing Qualifications staff of The Nasdaq Stock Market LLC stating that the Company's ordinary shares were subject to delisting from the Nasdaq Global Select Market, pending the Company's opportunity to request a hearing before the Nasdaq Hearings Panel. The Company submitted an appeal of the Notification on October 29, 2019. There can be no assurance, however, that the Panel will grant the Company's request for continued listing. Under Nasdaq rules, the delisting of the Company's ordinary shares and the suspension from trade in the Nasdaq will be stayed during the pendency of the appeal and during such time, the Company's ordinary shares will continue to be listed on The Nasdaq Global Select Market.

09:28 EDT Progress Software expands board to nine with appointment of Vivian Vitale - Progress announced the appointment of Vivian Vitale to its Board of Directors. Vitale's appointment expands the Progress Board to nine members, eight of whom are independent. Vitale is currently operating a consulting practice which assists organizations in developing people management practices, providing guidance and support in organizational transitions and coaching leaders for success.

09:25 EDT CleanSpark awarded $627,000 software controls, energy storage contract - CleanSpark announced an award of a contract totaling $627,000 to provide software controls and energy storage to Energias Limpias De CentroAmerica as part of their Energy as a Service project to support an industrial manufacturing facility in San Jose, Costa Rica. CleanSpark's solution will integrate a scalable 1110-kilowatt hours of battery storage paired with a 480-kilowatt solar photovoltaic system, all driven by CleanSpark's mPulse controls platform. CleanSpark's mPulse software will provide economic dispatch controls to maximize performance, as well as resiliency operations to back-up critical energy loads in the event of a utility disruption. The project is expected to be integrated and commissioned in the first quarter of 2020. In addition to the base contract, ELCA is entering into a Software as a Service agreement with CleanSpark for continued support of the system.

09:20 EDT Monaker Group expands board to eight with appointment of Alexandra Zubko - Monaker Group has appointed Alexandra Zubko to its board of directors. The appointment brings the total number of directors on the board to eight with six serving independently. Zubko co-founded and served as chief customer officer and general manager of Americas at Triptease, a provider of SaaS-based digital tools designed to create a seamless booking journey for hotel guests.

09:17 EDT Rafael Pharmaceuticals appoints Jose Octavia Costa Filho as CMO - Rafael Pharmaceuticals announced that Jose Octavio Costa Filho, M.D., will join the company as Chief Medical Officer. He will work alongside Timothy Pardee, M.D., Ph.D., who will continue in his role as co-CMO. They will both work together to continue the development of highly selective, well-tolerated and effective cell metabolic therapies to combat cancer. Dr. Costa Filho will oversee the solid tumor programs, while Dr. Pardee will remain focused on hematologic malignancies. Dr. Costa Filho joins Rafael from Servier Pharmaceuticals.

09:11 EDT General Electric says continuing to evaluate restructuring opportunities - Says: Expects sustained macro volatility for remainder of year... Making progress with headcount reduction... Working with Boeing (BA) and carriers to prepare for MAX return... Plans to remix Health unit to be more digital...Seeing strength in Aviation and Healthcare units.

09:10 EDT Synopsys and AMD execute multi-year ZeBu emulation agreement - Synopsys (SNPS) announced a multi-year agreement with AMD (AMD) to utilize its ZeBu Server 4 emulation system, accelerating verification of AMD high-performance processor, graphics, and gaming projects. As part of this new agreement Synopsys will optimize its ZeBu and VCS software for execution on AMD EPYC processor-based servers. AMD and Synopsys will extend their emulation collaboration to support system-level debug and analog/mixed-signal emulation, in addition to software-driven power and performance analysis, hybrid emulation, and virtual host solutions.

09:08 EDT TravelCenters to open up to 94 IHOP restaurants at locations - IHOP Restaurants, a subsidiary of Dine Brands (DIN), and TravelCenters (TA) announced that the two companies have entered into a franchise development agreement and plan to open up to 94 IHOP restaurants over the next five years in TA and Petro branded locations across the United States. Currently, there are four IHOP restaurants already in TA's travel center network, including one that opened this week in Jackson, Georgia. The agreement fulfills their joint commitment to bring guests meal choices and service while on the go. The IHOP restaurants in the portfolio will be operated by the TA Restaurant Group, a division of TravelCenters of America. Guests visiting IHOP restaurants located at TA travel centers will be able to enjoy the brand's full menu of made-to-order items. The deal with TravelCenters of America marks the single largest IHOP development deal in the brand's 61-year history.

09:07 EDT 2U appoints Jennifer Ogden-Reese as Chief Marketing Officer - 2U has hired Jennifer Ogden-Reese as its new Chief Marketing Officer, effective November 11. Ogden-Reese joins 2U from SeatGeek, a mobile-first live event ticketing platform, where she served as CMO for the last three years.

09:05 EDT Teradata enters strategic partnership with Deutsche Telekom - Teradata (TDC)and Deutsche Telekom (DTEGY) announced a strategic partnership at Digital X in Germany, where Oliver Ratzesberger, President and CEO at Teradata, and Hagen Rickmann, Director Business Customers at Telekom Deutschland, were presenting to an audience of 20,000. The partnership will support the digital transformation goals of small and medium sized businesses in Germany, giving them access to the enormous potential of data analytics to provide the insights required for growth and innovation.

09:04 EDT Rackspace selects Synchronoss Financial Analytics platform to manage costs - Synchronoss Technologies announced that Rackspace will use the Synchronoss Financial Analytics platform to manage costs, provide visibility and deliver savings by checking and validating the accuracy of its largest and most complex third party partner expenses and invoices. The Synchronoss platform will use advanced analytics to evaluate the complex, large-scale invoices that Rackspace receives from its partners each month. Each invoice can contain complex large datasets, which the Synchronoss platform will automatically process to identify potential anomalies and errors in the data. The automated process will improve accuracy, and will also provide expense governance to enable Rackspace to promptly recoup misbilled charges on its largest expenses.

09:02 EDT MongoDB, Alibaba Cloud launch new partnership - MongoDB (MDB) announced a partnership with Alibaba Cloud, the data intelligence backbone of Alibaba Group (BABA), to offer customers an authorized MongoDB-as-a-service solution. Customers of Alibaba Cloud will be able to use this managed offering from Alibaba Cloud's data centers globally. With this partnership, Alibaba Cloud ensures end-to-end management and support for customers on current and future versions of MongoDB, with the ability to escalate bug fixes and support issues on their behalf. Now, users of Alibaba Cloud's platform offering will have easy access to the latest MongoDB features and capabilities, backed by comprehensive support from Alibaba Cloud and MongoDB.

09:00 EDT Sky Solar announces closing of share purchase by Japan NK Investment - Sky Solar Holdings announced the closing of the transaction of purchasing 152,107,954 ordinary shares of the Company, at US$0.25 per ordinary share, or $2.00 per ADS, by Japan NK Investment K.K., from Flash Bright Power, Rihuaxing Limited, Sunpeak Universal Holdings, Inc. and Bright Reality Investment Limited, pursuant to an amended and restated stock purchase agreement dated October 21, 2019. Flash Bright is wholly owned by Mr. Weili Su, who left the company in June 2017 and was the controlling shareholder of the Company. Upon the completion of the transaction, Japan NK Investment K.K. holds 152,107,954 ordinary shares of the Company, representing 36.3% of the total shareholding, and Flash Bright and Mr. Su are no longer the controlling shareholders of the Company.

08:55 EDT Contango Oil & Gas announces closing of acquisition of Will Energy assets - Contango Oil & Gas Company announced that the Company has completed its previously announced acquisition of approximately 159,872 net acres located in North Louisiana and the Western Anadarko Basin in Western Oklahoma and the Texas Panhandle from Will Energy Corporation for an aggregate consideration of $23 million. Following adjustments for recent sales of non-core, non-operated Louisiana properties by Will Energy, the results of operations for the period between the effective and closing dates, and other estimated customary closing adjustments, the consideration paid at closing consisted of $14.75 million in cash and 3,500,000 shares of common stock. The Properties are approximately 95% held by production, and currently produce approximately 1,400 boepd with 34% of that production comprised of liquids. Approximately 75% of that production is operated. The Properties are mature fields with existing cash flow, low decline and significant development potential from PDNP and PUD opportunities.

08:53 EDT Perspecta awarded $25M Army task order - Perspecta's innovative research arm, Perspecta Labs, was awarded a task order from the U.S. Army as the Applied Research and Experimentation Partner for the cybersecurity Collaborative Research Alliance program. The program, which represents continuing work for the company, has a maximum potential value of $25M over a five-year period of performance if all options are exercised. The cybersecurity CRA is a collaborative alliance between the Combat Capabilities Development Command Army Research Laboratory, CCDC C5ISR Center, academia and industry to advance the foundation of cyber science in the context of Army networks. Perspecta Labs has been conducting research as a member of the CRA since 2014. Under the new AREP task order, Perspecta Labs will continue to support the CRA with applied research and experimentation and assist with the accelerated transition of this research into the field.

08:46 EDT Poet Technologies to close sale of DenseLight subsidiary on or before Nov. 8 - POET Technologies announced that the Closing of the sale of the Company's subsidiary, DenseLight Semiconductors to DenseLight Semiconductor Technology will close on or before Friday, November 8, 2019. Widely reported instances of more strict and careful review of foreign currency conversion applications by regulators in the Peoples Republic of China have curtailed several forms of foreign investment by Chinese investors and prolonged the Overseas Direct Investment process. In the case of the sale of the shares of DenseLight to the Buyer, the result is a short delay in the ODI process and subsequent transfers needed to make the first tranche payment of $8 million to the Company. With the extended review process likely to continue for some time, and to ensure that all interested investors in DL Shanghai are able to participate, the Company has agreed to receive the total purchase price of $26 million in three tranches, with the first being a payment of $8 million on or before November 8, plus two additional installments of $13 million on or before December 31, 2019 and another for $5 million on or before May 31, 2020. The additional $2 million to be paid on behalf of the Buyer to Oak Capital for due diligence, legal and other expenses will be made to POET and remitted to Oak Capital with the second tranche payment. The Buyer has provided documentary evidence that the funds needed for the first tranche payment are present in its accounts and will continue to inform the Company on the status of its ODI applications, conversion to US dollars and associated bank transfers. The sale will close upon receipt of the $8 million into POET's account. The Company also announced that it had received final approval for the sale transaction from the TSX Venture Exchange and confirmed, as previously agreed between the Buyer and the Company, that DL Shanghai will be responsible for the operating expenses of DenseLight Singapore beginning on November 1, 2019.

08:43 EDT Agraflora Organics receives purchase order from Asian CBD distribution JV - AgraFlora Organics International announced the Company has received its inaugural purchase order from its 50 per-cent owned joint venture, Eurasia Infused Cosmetics. Eurasia Infused, by way of a commercial concession with CBD Group Asia, controls distribution agreements for CBD and organic cannabis sativa seed oil infused consumer packaged goods, for the territories of People's Republic of China, as well as the Hong Kong special administrative region. This distribution agreement extends to AgraFlora's existing portfolio of CBD-infused and organic cannabis sativa seed oil derived product suite. On October 25, 2019, the JV issued AgraFlora an initial purchase order to supply its organic cannabis sativa seed oil infused face serum and lip balm. This initial purchase order will secure high-visibility Asia Pacific shelf space for AgraFlora's existing CPG product offering.

08:39 EDT Cohen & Co. reports Q3 EPS ($1.06) vs. (57c) last year - Reports Q3 revenue $11.3M vs. $12.23M last year. Lester Brafman, CEO of Cohen & Company, said, "Our third quarter performance was impacted by the shock to overnight repo funding rates in September and slower than anticipated growth from new issue revenue opportunities. While we are disappointed with our results from the quarter, we are pleased with the overall growth in our Mortgage business, as our TBA and Gestational Repo businesses have reached all-time highs in terms of volume and revenues. We continue to believe that the initiatives underway will generate long-term value for our shareholders, and we are focused on improving these results going forward."

08:39 EDT Yum! Brands announces promotion of Gavin Felder to Chief Strategy Officer - Comments provided during Q3 earnings conference call

08:34 EDT Emcore announces sale of CATV production assets for $5.5M - EMCORE Corporation announced the sale of its Cable TV production equipment and transfer of its CATV manufacturing operations from the Company's Beijing facility to Hytera Communications Company Limited and Shenzhen Hytera Communications Co. The sale price for the equipment is approximately $5.5M and is expected to be received by EMCORE beginning in the December 2019 quarter and continuing through the September 2020 quarter. Hytera will use the equipment to manufacture CATV components and subsystems from its facility in Southeast Asia. On its fiscal third quarter 2019 earnings call, EMCORE discussed plans to take four actions to improve profitability and cash flow while eliminating exposure to tariffs associated with the import of products manufactured in China. With the execution of this agreement and subsequent production transfer to Hytera, EMCORE will complete the first of these actions -- streamlining operations and moving to a variable cost model in EMCORE's CATV product lines. Additionally, EMCORE completed two other actions in the quarter by reducing the size of its CATV team and reducing the capacity of EMCORE's wafer fab to one shift. These actions incurred one-time costs of $0.4M in the quarter ended September 30, 2019 and are expected to result in annual cash savings of approximately $3M beginning in the December 2019 quarter. These operational changes in CATV also fulfill a strategic objective of positioning the CATV product lines to generate positive cash flow to help fund the other growth areas of EMCORE in Aerospace and Defense.

08:32 EDT Farmer Bros. stockholders urge fellow stockholders to vote for their nominees - Jeanne Farmer Grossman, Thomas William Mortensen, and Jonathan Michael Waite announced today that they issued an open letter urging stockholders of Farmer Bros. Co. to STOP, LOOK and LISTEN before taking any action in response to the Company's solicitation of proxies for the 2019 Annual Meeting of Stockholders. The complete text of the letter to stockholders follows: The letter said, in part, " You will soon receive or may have already received a proxy statement and accompanying white proxy card from Farmer Bros. Co. in connection with the upcoming 2019 Annual Meeting of Stockholders of the Company..We strongly urge you NOT to return the white proxy card or voting instruction form from the Company and NOT to allow the Company to take your vote over the telephone or by internet, but to wait until you receive and review our definitive proxy materials and GOLD proxy card, which we will be sending to you soon, before voting. If you have already voted the Company's white proxy card or voting instruction form or had your vote taken by the Company over the telephone or by internet, a later-dated GOLD proxy card will revoke your previously cast vote. We are seeking your support for the election of our two highly qualified nominees, Thomas William Mortensen and Jonathan Michael Waite, to the Company's Board of Directors, due to our continued frustration with the performance of Farmer Bros. and our concerns that the Board is not taking the appropriate action to maximize stockholder value. As shown in the Company's own proxy statement, the Company's three-year cumulative Total Shareholder Return of -49% significantly underperformed the general market and its peer group, which had a TSR of +40%. We strongly believe that the Board must be reconstituted to ensure that the directors take the necessary steps for the Company's stockholders to realize the maximum value of their investment. We strongly urge you to wait for and carefully consider the information contained in the Concerned Stockholders' proxy materials and the GOLD proxy card prior to casting your vote in connection with the Annual Meeting."

08:25 EDT Atlas Air sees FY19 revenue approx. $2.75B, consensus $2.86B

08:22 EDT 8x8, Inc., Poly and Scansource announce joint global CloudFuel program - 8x8 Inc. (EGHT), Poly (PLT) and ScanSource (SCSC) announced they are joining forces to help companies move away from legacy on-premises business communication systems to true cloud-based communication solutions. The joint global program, named CloudFuel, will accelerate the process of ensuring organizations have proven cloud technology to meet all of their needs across unified communications, collaboration and contact center. This is the first time a hardware replacement/cloud migration program will be offered to the VAR channel, combining award-winning UCaaS and CCaaS solutions on 8x8's single technology platform, equipment from Poly and powerful financial incentives for ScanSource resellers, who are the critical parties with the end customer relationships. The move from on-premises systems to cloud-based communications is accelerating. The CloudFuel program will be offered through the ScanSource network of more than 35,000 resellers and will provide access through their direct relationships to hundreds of thousands of customers across the globe.

08:17 EDT Cellectar Biosciences presents new phospholipid drug conjugate - Cellectar Biosciences announced Jarrod Longcor, chief business officer of Cellectar, presented a poster highlighting preclinical data with CLR 180099 at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference, being held from October 26-30, 2019 in Boston, MA. CLR 180099 is a Phospholipid Drug Conjugate composed of a uniquely designed phospholipid ether conjugated to a flavaglin analogue payload. The poster, entitled: "CLR 180099, a lipid raft targeted phospholipid-drug conjugate, shows potent improved safety and efficacy against colorectal tumors," highlighted data demonstrating a greater reduction in tumor volume and improved survival with CLR 180099 than docetaxel in a colorectal cancer model. Additionally, as compared to the FLV payload alone, the PDC demonstrated improved tolerability with greater than a 20 fold increase in the maximum tolerated dose. CLR 180099 was also shown to have potent nanomolar activity in other select solid tumorsincluding breast cancer and lung cancer models.

08:12 EDT LPL Financial announces proposed leverage-neutral transaction - LPL Financial Holdings announced that its wholly owned subsidiary, LPL Holdings, intends to reprice its existing $1,470 million term loan B, increase the size of its revolving credit facility from $500 million to $750 million, extend the maturity date applicable to its term loan B and revolving credit facility, and make certain other changes. Additionally, LPL Holdings announced that it intends to offer approximately $400 million in aggregate principal amount of senior unsecured notes due 2027. The aggregate amount of LPL's outstanding indebtedness would be substantially unchanged as a result of the transaction, as LPL Holdings intends to use the net proceeds from the senior notes offering, together with cash available for corporate use, to pay down its existing term loan B to approximately $1,070 million and to pay fees and expenses related to the senior notes offering and the credit agreement amendment. LPL Holdings expects to complete the transaction by the end of November 2019. The launch and consummation of the credit agreement amendment and the senior notes offering are subject to market and other conditions.

08:10 EDT Cyclerion: Phase 2 study of praliciguat did not reach statistical significance - Cyclerion Therapeutics announced topline results from its Phase 2 proof-of-concept study of praliciguat, a once-daily, orally available systemic sGC stimulator, in diabetic nephropathy. The study did not meet statistical significance on its primary endpoint of reduction in albuminuria from baseline as compared to placebo, measured by urine albumin creatinine ratio (UACR), but there was a trend toward improvement across the total intention-to-treat study population. In addition, improvements were observed in patients treated with praliciguat in several secondary vascular and metabolic measures associated with cardiovascular risk and kidney disease progression, including blood pressure, cholesterol and HbA1c levels, compared to placebo. All patients were on concomitant stable standard of care therapy, including anti-diabetic medications and renin-angiotensin-aldosterone system blockers. As in prior clinical studies, the pharmacokinetic profile of praliciguat was consistent with once-daily dosing. Praliciguat was generally well tolerated, and the safety profile was supportive of continued development. During statistical validation, data from one clinical trial site were found to be inconsistent with those of the overall study population. At this site, a significantly greater percentage of patients assigned to the praliciguat treatment arms had undetectable or very low praliciguat plasma concentrations than was seen across the broader study population. In a post-hoc sensitivity analysis in which data from this site are excluded, an increased treatment effect and reduced variability are observed. As previously announced, Cyclerion intends to out-license praliciguat for late-stage global development and commercialization. Cyclerion also announced the results of its Phase 2 proof-of-concept study of praliciguat in heart failure with preserved ejection fraction. Full results from both studies will be presented at future medical meetings. The company expects to deliver results from its STRONG SCD Phase 2 study of olinciguat, an sGC stimulator under investigation as a potential treatment for sickle cell disease in mid-2020, its Phase 1 study of IW-6463, a central nervous system-penetrant sGC stimulator, in Q4 2019. With its praliciguat Phase 2 studies completed, Cyclerion intends to focus its investments on these near-term value-creation opportunities, as well as ongoing innovation, and to reduce its monthly cash expenses by 25%. As of September 30, 2019, Cyclerion had approximately $125 million of cash, cash equivalents and restricted cash. Cyclerion anticipates that this cash will be sufficient to fund its operations through Q1 2021.

08:09 EDT Curaleaf Holdings' acquisition of Select brand to advance on amended terms - Curaleaf Holdings has agreed with Cura Partners, owners of the Select brand, to amend the terms of their prior agreement for Curaleaf's acquisition of Select's state-regulated cannabis business. Additionally, the waiting period under the HSR Antitrust Improvements Act of 1976 has expired with respect to the acquisition of Select by Curaleaf. Due to changes in market conditions since the original merger agreement was signed in May, Curaleaf and Select have mutually agreed to reduce the base consideration payable upon close under the Proposed Transaction. Under the amended and restated merger agreement, the number of subordinate voting shares of Curaleaf payable at closing of the Proposed Transaction has been reduced to 55M SVS of Curaleaf from 95,555,556 originally. The remaining 40,555,556 SVS will now be payable to Select equity holders contingent upon Curaleaf achieving certain calendar year 2020 revenue targets based on Select-branded retail extract sales beginning at a target of $130M with maximum achievement at $250M. In addition, Select equity holders will also be eligible to receive an earn-out of up to $200M from the issuance of additional SVS, contingent upon Curaleaf exceeding $300M in calendar year 2020 revenue for Select-branded retail extract sales. The companies continue to work with state regulators to receive the necessary approvals with a target closing date of January 1, 2020. The terms of the Amended Merger Agreement have been unanimously approved by independent special committees of the Boards of Directors at both companies.

08:06 EDT Cyclerion Therapeutics to discontinue development of praliciguat in HFpEF

08:05 EDT Activision Blizzard announces over $600M in sell through for new Call of Duty - Activision Blizzard's Call of Duty: Modern Warfare had more than $600M in sell-through worldwide in its first three days of release. The title has sold more units in its first three days than any other Call of Duty game sold in its first three days in this console generation, and is the top-selling new premium game release of 2019. Modern Warfare also established a new record as the number one top-selling digital opening in Activision history. With its blockbuster launch, in its first three days of release, Call of Duty: Modern Warfare more than doubled the box office opening of Joker. Modern Warfare set new records on the PlayStation Network (SNE) for the highest digital pre-orders and highest three-day digital sales ever on PlayStation 4. Modern Warfare also has become the number one top-selling Call of Duty PC launch ever, as opening weekend PC sales on Blizzard Battle.net were significantly up over last year. Sell-through sales figures include Call of Duty: Modern Warfare retail and digital unit sales and revenues, including sales of the Defender DLC pack, for the opening three days following initial launch. Sales figures based on retail customer sell-through information and Activision data and estimates. Reported movie sales according to publicly available data. Total players and total hours played based on Activision data. Top selling new premium release of the year based on Activision data and internal estimates, and excludes free-to-play games. Activision's new thriller unites the Call of Duty community to play together through crossplay and cross progression support, and to enjoy new post-release content coming free for all players on all platforms.

08:01 EDT Airbus maintains FY19 EBIT adjusted view up approximately 15% - As the basis for its 2019 guidance, the company expects the world economy and air traffic to grow in line with prevailing independent forecasts, which assume no major disruptions. The 2019 earnings and Free Cash Flow guidance is before M&A. Airbus now targets around 860 commercial aircraft deliveries in 2019, which reflects the updated delivery schedule. On that basis: Airbus maintains its expected increase in EBIT Adjusted of approximately +15% compared to 2018. Airbus now expects FCF before M&A and Customer Financing of approximately EURO$ 3 billion.

07:54 EDT Clearside announces option exercise by Regenxbio for SCS Microinjector - Clearside Biomedical (CLSD) announced that REGENXBIO (RGNX) has exercised its option under the previously announced option and license agreement to license Clearside's proprietary, in-office SCS Microinjector for the delivery of adeno-associated virus-based therapeutics, including but not limited to RGX-314 delivery to the suprachoroidal space to potentially treat wet age-related macular degeneration, diabetic retinopathy, and other conditions for which chronic anti-vascular endothelial growth factor treatment is currently the standard of care. Under the terms of the option and license agreement, Clearside earned $2.0 million related to REGENXBIO's exercise of the option and signing of the original research agreement. Clearside is also eligible to receive up to $34 million in total development milestones across multiple indications, up to $102 million in sales milestones and mid-single digit royalties on net sales of products using the SCS Microinjector. REGENXBIO will be responsible for all development, regulatory and commercialization activities for their gene therapy product candidates. Clearside will be responsible for supplying the SCS Microinjector in support of REGENXBIO's preclinical studies, clinical studies and commercial use.

07:47 EDT Emerald Health eliminates approx. 20 positions, announces COO, CFO departures - Emerald Health Therapeutics has announced an internal reorganization including the reduction of its workforce and other expenditures. It is at the same time reinforcing its commitment to new product development focused on enhancing the modulation of the body's endocannabinoid system. These changes are focused on improving cash flow in the near term and the goal of building long term profitability. As part of the reorganization, Emerald eliminated approximately 20 staff positions yesterday and has reduced its workforce by approximately 65 staff positions, or 33% of its total workforce, since August 1, 2019. The reductions include the departure of Rob Hill, CFO, and Sean Rathbone, COO. Ms. Jenn Hepburn, previously Director, Finance, has been appointed CFO and Corporate Secretary, effective immediately. Dr. Avtar Dhillon, currently President and Chairman of Emerald, will cease to be President and will continue as Executive Chairman. Mr. Riaz Bandali, CEO of Emerald, will continue as President and CEO. The reorganization is not expected to impact Emerald's cannabis production or its client service. Management expects that the reorganization will enable Emerald to realize material cost savings beginning in the first quarter of 2020. Emerald remains committed to investing in its innovation and new product development activities.

07:44 EDT Seneca Biopharma, QYuns Therapeutics sign licensing agreement - Seneca Biopharma, (fka Neuralstem) and Jiangsu QYuns Therapeutics Co., a China-based company focused on monoclonal antibody therapeutics, jointly announce that they have entered into a non-binding term sheet for the licensing of certain assets owned by QYuns. Subject to entering into definitive agreements and receiving necessary approvals, Seneca and QYuns will enter into a royalty- and milestone-free, perpetual, non-cancelable, exclusive worldwide, other than in Greater China (which includes Hong Kong, Macau and Taiwan and certain other Asian territories) license to develop and commercialize certain of QYuns' assets, including QX005N, targeting IL-4Ralpha, QX002N, targeting IL-17A, QX004N targeting IL-23A, and QX006N targeting IFNRalpha. As contemplated by the term sheet, Seneca will also gain access to future antibody assets developed by QYuns and the parties will collaborate on future pipeline expansion. Upon entering into the license, Seneca's lead asset will be SNC005 that targets IL-4Ralpha for the treatment of Asthma and Atopic Dermatitis. As consideration for the license, Seneca will issue QYuns a yet to be determined amount of common stock.

07:43 EDT Tupperware Brands down 14% after Q3 results, FY19 guidance miss estimates - In pre-market trading, shares are down approximately 14% to $13.39.

07:35 EDT Hess Corp. ups FY19 production view to 285,000 boped from 275.000-280,000 boepd - Bakken net production guidance increased to approximately 150,000 boepd, up from the previous guidance range of 140,000-145,000 boepd. E&P capital and exploratory expenditures are projected to be $2.7B, down from previous guidance of $2.8B.

07:32 EDT Biogen, Alkermes announce FDA approval of VUMERITY - Biogen (BIIB) and Alkermes (ALKS) announced that the U.S. FDA approved VUMERITY, a novel oral fumarate with a distinct chemical structure, for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. Biogen holds the exclusive, worldwide license to commercialize VUMERITY and intends to make it available in the United States in the near future. Under the terms of the license and collaboration agreement between Biogen and Alkermes, Biogen will pay Alkermes $150M in connection with the FDA's approval of VUMERITY. Biogen plans to account for this milestone payment as an asset that will be amortized over the expected useful life of the product. Alkermes is also entitled to receive a mid-teens percentage royalty on worldwide net commercial sales of VUMERITY, subject, under certain circumstances, to minimum annual payments for the first five years following FDA approval and customary reductions as set forth in the agreement.

07:27 EDT James E Wagner, Fluence enter agreement to test impact of LED lighting - James E. Wagner Cultivation announced that its wholly-owned subsidiary, James E. Wagner Cultivation Ltd., has entered into a mutually collaborative product trial and evaluation agreement with Fluence Bioengineering to test and provide feedback regarding the performance, functionality and suitability of Fluence's VYPR 2p Broad Spectrum LED lighting solution. Analysis will be conducted under the Agreement for a term of eight months to assess whether JWC can further improve its high level of energy efficiency by using lighting equipment provided by Fluence to help optimize cultivation performance at its flagship JWC2 facility located at 530 Manitou Drive, Kitchener, Ontario. Throughout the term of the Agreement, Fluence will visit JWC to provide assistance with data collection, training on best practices for cultivating with LED lighting solutions and recommendations for climatic parameters to promote optimal plant growth. In turn, JWC will provide data analysis to Fluence with respect to cultivation performance in the flowering rooms utilizing Fluence's lighting solutions. If the project is successfully completed in accordance with the criteria set out in the Agreement, JWC intends to extend the relationship with Fluence by purchasing certain equipment from Fluence.

07:25 EDT Cyclerion Therapeutics Inc trading halted, news pending

07:25 EDT Microbot Medical receives notice of allowance for U.S. patent covering TipCAT - Microbot Medical announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for patent application No. 15/218,025, covering the Company's TipCAT technology platform. The allowed patent application is a Continuation of Patent No. 9,427,143, issued on August 30, 2016. The allowed patent application covers a self-propelled device for locomotion through a lumen, the device comprising a set of serially arranged inflatable chambers configured for sequential inflation from a single fluid source, wherein at least one chamber has characteristics selected to provide a non-monotonous relationship between the inflation pressure within the chamber and its inflated size.

07:22 EDT Roadrunner offering free Transportation Management System - Roadrunner's business unit Roadrunner Freight has partnered with MyCarrierTMS to offer customers a free transportation management system, or TMS, called RapidShip. The TMS offers a single-page view for quotes, real-time tracking information, carrier consolidation and a calendar view of upcoming and current shipments.

07:16 EDT Bell Media announces new long-term exclusive deal with Warner Bros. - Bell Media announced a new long-term exclusive deal with Warner Bros. International Television Distribution that brings original programming from WarnerMedia's HBO Max to Canada, beginning in 2020. The announcement is the first for HBO Max programming outside of the U.S. The agreement extends Bell Media's programming partnership with HBO, one of the world's most prestigious entertainment brands, expanding the company's HBO content offering on its SVOD service, Crave, and reinforcing Bell Media's commitment to delivering the most sought-after programming in the world. It also establishes a new alliance with HBO Max, making original series from the highly anticipated new service available to Canadians via Crave and Bell Media's suite of CTV-branded platforms. The deal extends the pay TV rights for Warner Bros first-run feature films adding to the strong relationship already in place between Warner Bros. and CTV for network series, and with Bell Media's specialty services for cable series. The deal encompasses new scripted series primarily produced by the divisions of the Warner Bros. Television Group for HBO Max. Specific details on the rollout of HBO Max programming in Canada will be confirmed in the coming months.

07:15 EDT Crocs up 1.3% after reporting Q3 results

07:13 EDT Athenex announces European orphan designations for paclitaxel, encequidar - Athenex announced that it has received Orphan Designations from the European Commission for paclitaxel and encequidar for the treatment of soft tissue sarcoma, following a positive opinion from the European Medicines Agency. The U.S. FDA has granted oral paclitaxel and encequidar an Orphan Drug Designation in the treatment of angiosarcoma.

07:11 EDT Crocs reports Q3 retail SSS up 12.5%

07:10 EDT Molson Coors estimates revitalization plan cost of $120M-$180M - In connection with these consolidation activities and related organizational and personnel changes, which were determined and initiated on October 28, 2019, the company currently expects to incur certain cash and non-cash restructuring charges related to employee relocation, severance, retention and transition costs, non-cash asset related costs, lease exit costs in connection with office leases in Denver, Colorado, and other transition activities estimated in the range of approximately $120 million to $180 million in the aggregate, the majority of which will be cash charges that will be spread through the balance of this fiscal year and fiscal years 2020 and 2021. The consolidation activities are expected to be substantially completed by the end of fiscal year 2021. Costs related to these restructuring activities are expected to be recorded as special items within our financial results beginning in the fourth quarter of 2019.

07:08 EDT Criteo sees Q4 adjusted EBTIDA $99M-$105M - The company said, "We expect Revenue ex-TAC to be between $255 million and $261 million, implying constant-currency growth of approximately -5% to -3%. We expect Adjusted EBITDA to be between $99 million and $105 million."

07:05 EDT Carlyle Group to acquire insurance broker The Hilb Group - The Carlyle Group has signed a definitive agreement with The Hilb Group, a national insurance broker, for investment funds affiliated with Carlyle to acquire a majority interest of Hilb. Hilb's existing management team and employee shareholders are expected to remain significant shareholders. Hilb is currently a portfolio company of Abry Partners, a Boston-based private equity firm. Founded in 2009, Hilb employs more than 900 associates and operates 91 branch offices serving all 50 states. Equity capital for the investment will come from Carlyle Partners VII, an $18.5B fund that focuses on buyout transactions in the U.S., and Carlyle Global Financial Services Partners III, L.P., a dedicated financial services buyout fund. The transaction is expected to be completed in Q4. Financial details of the transaction were not disclosed.

07:03 EDT Molson Coors backs FY19 underlying cash flow outlook of $1.4B, +/- 10% - Backs FY19 view of CapEx approx $700M, +/- 10%, consolidated Cost of Goods Solid mid-single digit increase on a constant currency basis and effective tax rate of 18%-22%.

07:00 EDT McDermott signs MOU with Darwin Clean Fuels - McDermott announced the signing of a Memorandum of Understanding, or MOU, with Darwin Clean Fuels. The MOU is for the feasibility study, technology, front-end engineering design, or FEED, and engineering procurement and construction, or EPC, for a Clean Fuels Condensate Processing Plant in Darwin, in the Northern Territory, Australia.As part of the initial contract, McDermott will undertake the feasibility study and FEED through to final investment decision. Upon final investment decision, McDermott will be the lead EPC contractor for the refinery. Early phase engineering work will commence immediately and be completed by quarter one in 2020.

06:59 EDT Molson Coors reports Q3 worldwide brand volume down 2.4% - The company states: "Q3 worldwide brand volume and financial volume decreased 2.4% and 5.5%, respectively, due to declines in all segments, partially driven by challenging industry dynamics. Financial volume was further impacted by quarterly timing of customer inventory levels in the U.S. and Canada, as well lower contract brewing volume."

06:57 EDT Bayer confirms outlook for 2019 issued in February - Bayer said in a statement: "Bayer has confirmed the outlook for fiscal 2019 published in February of this year, which was issued on the basis of all businesses being continuing operations. In view of the progress that has since been made with the divestment of Animal Health and the stake in Currenta, the original forecast has been aligned to exclude the sales and earnings contributions from these businesses, which are now reported as discontinued operations. Current exchange rates have also been taken into account. On this aligned basis, Bayer anticipates Group sales of approximately 43.5 billion euros, which continues to correspond to an increase of around 4 percent on a currency- and portfolio-adjusted basis. On the same basis, EBITDA before special items in fiscal 2019 is expected to come in at around 11.5 billion euros."

06:52 EDT Credit Suisse sees headwinds from ongoing challenging geopolitical environment - Credit Suisse said: "As we head into the final quarter of 2019, we expect to see the usual seasonal slowdown as a result of the holiday season in many parts of the world. We also expect headwinds from the ongoing challenging geopolitical environment, most notably the US-China trade dispute and Brexit, to persist. This is likely to lead to more cautious capital expenditure and investment decisions, specifically looking forward to 2020 and 2021. That said, we believe that the long-term outlook remains attractive in wealth management, as indicated by the findings of our latest Global Wealth Report7 , and through our integrated approach, we expect to capitalise on these trends. Since 2016, we have significantly de-risked the bank and lowered the cost base, and we believe we are well positioned to outperform on a relative basis."

06:49 EDT BWX Technologies says plans to produce medical radioisotope Germanium-68 - BWX Technologies announced that it plans to produce the medical radioisotope Germanium-68 (Ge-68) with a focus on addressing a growing global demand for the product. BWXT's isotope technologies group in Canada has developed proprietary manufacturing technology to produce high purity Ge-68 and is in the process of scaling up its capacity to move into full production in 2020 to address growing global customer demands. Ge-68 will be produced using cyclotrons at BWXT's Vancouver facility located on the TRIUMF site. TRIUMF, which is Canada's particle accelerator center, and BWXT's medical isotopes group have been working together to support medical isotope production for over 40 years. BWXT's Ge-68 product will be used in Gallium-68 (Ga-68) generators, a source of the diagnostic radioisotope Ga-68. Using specific disease-targeting molecules, Ga-68 provides diagnoses and enables treatment planning using positron emission tomography. Diagnostic applications for Ga-68 include prostate cancer and neuroendocrine tumors. In addition, a number of other therapeutic and Ga-68 imaging agents are in various stages of development and clinical trials that are expected to result in a further increase in demand for Ga-68.

06:48 EDT Baker Hughes CEO says 'firmly on the right path' - "We delivered a solid third quarter with strong growth in Turbomachinery and Oilfield Equipment orders, and continued margin improvement in our Oilfield Services business. Overall, we are very pleased with our execution as a team, and we believe Baker Hughes is firmly on the right path financially, operationally, and strategically," said Lorenzo Simonelli, Baker Hughes Chairman and CEO.

06:45 EDT Epizyme reports positive pre-NDA meeting for tazemetostat in lymphoma - Epizyme announced recent tazemetostat program updates, including completing a pre-NDA meeting with the FDA for its tazemetostat program for follicular lymphoma and G9a program updates. During a recent pre-NDA meeting, Epizyme gained alignment with the FDA that the proposed data package is sufficient to support a submission for accelerated approval of tazemetostat as a monotherapy for relapsed or refractory FL patients, both with EZH2 activating mutations and wild-type EZH2, who have received at least two prior systemic therapies. Epizyme is on track to submit the NDA for this indication in December 2019. Epizyme gained alignment with FDA on a single confirmatory trial to support a submission for full approval. This global, randomized, adaptive trial will evaluate the combination of tazemetostat with "R2", an approved chemo-free treatment regimen, for FL patients in the second-line or later treatment setting. The trial is on track to begin in Q4.

06:40 EDT Aerie Pharmaceuticals names David Hollander as Chief R&D Officer - Aerie Pharmaceuticals announced the appointment of David Hollander, M.D., M.B.A., as Chief Research & Development Officer, an executive officer position reporting to Vicente Anido, Jr., Ph.D., Aerie's Chairman and CEO. Dr. Hollander will commence his employment at Aerie on November 11 and will direct the company's preclinical and clinical research and development groups, as well as medical and professional affairs. He was most recently Chief Medical Officer, Senior Vice President at Ora, Inc.

06:28 EDT Anixter to be acquired by Clayton, Dubilier & Rice for $81.00 per share in cash - Anixter has entered into a definitive agreement with an affiliate of Clayton, Dubilier & Rice to be acquired in an all cash transaction valued at approximately $3.8B. The transaction will result in Anixter becoming a private company and is expected to close by the end of the first quarter of 2020. Under the terms of the merger agreement, CD&R-managed funds will acquire all of the outstanding shares of Anixter common stock for $81.00 per share in cash. This represents a premium of approximately 13% over Anixter's closing price on October 29, and a premium of approximately 27% over the 90-day volume-weighted average price of Anixter's common stock for the period ended October 29. It is anticipated that upon completion of the transaction, Bill Galvin, along with other members of Anixter's executive management team, will continue to lead the company. Anixter's Board of Directors has unanimously approved the agreement with CD&R and recommends that Anixter stockholders approve the proposed merger and merger agreement. Anixter expects to hold a Special Meeting of Stockholders to consider and vote on the proposed merger and merger agreement as soon as practicable after the mailing of the proxy statement to its stockholders. Under the terms of the merger agreement, Anixter may solicit superior proposals from third parties for a period of 40 calendar days continuing through December 9, 2019. In accordance with the merger agreement, Anixter's Board of Directors, with the assistance of its advisors, intends to solicit superior proposals during this period. In addition, Anixter may, at any time, subject to the provisions of the merger agreement, respond to unsolicited proposals that are reasonably likely to result in a superior proposal. Anixter advises that there can be no assurance that the solicitation process will result in an alternative transaction. To the extent that a superior proposal received prior to December 9, 2019 or, in certain circumstances, 10 days thereafter leads to the execution of a definitive agreement, Anixter would be obligated to pay a $45M break-up fee to CD&R. Anixter does not intend to disclose developments with respect to this solicitation process unless and until it determines it is appropriate to do so.

06:25 EDT Edison International CEO says 'likely' equipment associated with Woolsey Fire - In his prepared earnings remarks, Edison International President and CEO Pedro Pizarro said Southern California Edison "believes it is likely that its equipment was associated with the ignition of the Woolsey Fire" that devastated southern California in late 2018.

06:20 EDT Summit Materials narrows FY19 adjusted EBITDA view to $440M-$460M - Summit narrowed its 2019 full year Adjusted EBITDA guidance to $440M-$460M from $430M-$470M.CEO Tom Hill continued, "Based on our performance year to date and anticipating normal weather conditions, we believe it makes sense to narrow our guidance range for the year." The company narrowed its guidance for 2019 capital expenditures to approximately $160M-$170M from $160M-$175M. The company reiterated its guidance to reduce its leverage ratio by year-end 2019.

06:17 EDT McEwen Mining sees Q4 production 42K-46K gold equivalent ounces

06:13 EDT GE says 'still early' in multi-year transformation - Says "still early" in multi-year transformation, says 2020 and 2021 will be "meaningfully better."

06:11 EDT General Electric reports Q3 Power revenue $3.93B vs. $5.52B last year - Reports Renewable Energy revenue $4.4B vs. $3.92B last year. Reports Aviation revenue $8.11B vs. $7.48B last year. Reports Healthcare revenue $4.92B vs. $4.71B last year.

06:07 EDT General Electric reports total orders of $22.5B in Q3, down 5% - GE Industrial profit margin was (2.1%); adjusted GE Industrial profit margin was 10%.

06:03 EDT SiteOne Landscape narrows adjusted EBITDA view to $197M-$203M from $193M-$207M

05:52 EDT HC2 Holdings announces sale of Huawei Marine Networks JV - HC2 Holdings announced that its Marine Services Segment, Global Marine Group, or GMG, has agreed to a sale of its stake in Huawei Marine Networks Co., Limited, or HMN, its 49% joint venture with Huawei Technologies, to Hengtong Optic-Electric. The sale of GMG's interest values HMN at $285 million, and GMG's 49% stake at approximately $140M. Under the agreement, GMG will sell 30% of HMN to Hengtong at closing and retain a 19% interest in HMN under a two-year put option agreement at the greater of the same equity value or fair market value. Hengtong is also purchasing Huawei's full 51% stake and will own 81% of the joint venture upon the closing of both sales, and 100% upon the exercise of GMG's put option. Completion of the sale is expected during the first quarter of 2020, subject to customary closing conditions, with proceeds delivered to GMG at that time. After satisfaction of any pending obligations and in concert with any sale of Global Marine Systems Limited, HC2's share of the net proceeds from the HMN sale will be utilized to reduce debt at the HC2 holding company level.

05:42 EDT Fiat Chrysler confirms strategic transaction talks with Peugeot - Following recent reports on a possible business combination between Groupe PSA (PUGOY) and FCA Group, Fiat Chrysler Automobiles N.V. (FCAU), confirms there are ongoing discussions "aimed at creating one of the world's leading mobility Groups." FCA has nothing further to add at this time.

05:35 EDT Genentech announces FDA acceptance of BLA for satralizumab - Genentech, a member of the Roche Group, announced that the FDA has accepted the company's Biologics License Application, or BLA, for satralizumab for the treatment of adults and adolescents with neuromyelitis optica spectrum disorder, or NMOSD. The European Medicines Agency, or EMA, has also validated the company's Marketing Authorization Application, or MAA, for satralizumab, granting it Accelerated Assessment. The FDA decision and the EMA's Committee for Medicinal Products for Human Use, or CHMP, recommendation are expected in 2020.

05:19 EDT Strata Skin Sciences receives extension to stay of suspension from Nasdaq - Strata Skin Sciences announced that it has been granted an extension to its stay of suspension from Nasdaq. The company will continue to trade pending a hearing on November 21, following which the Nasdaq Hearings Panel will make a decision about the company's listing based on its full and complete record at that time. To be in full compliance with the Nasdaq listing requirements, the company must be current with its Annual and Quarterly Reports on Forms 10-K and 10-Q, respectively, with the SEC. As part of gaining compliance with the listing requirements, the company filed its Annual Report on Form 10-K for the year ended December 31, 2018 on October 29, 2019. Additionally, it projects to file its Quarterly Report on Form 10-Q for the first quarter of fiscal 2019 during the week of November 4 and its Form 10-Q for the second quarter of fiscal 2019 during the week of November 11. It further anticipates, based on timeline discussed with its auditors, that the company will be timely in filing the Quarterly Report on Form 10-Q for the third quarter of fiscal 2019 on November 14. Should the company file in this manner, the company anticipates filing an amendment to its 2018 Annual Report on Form 10-K/A after the filing of the second quarter 10-Q in order to file certain consents by its independent audit firms regarding certain existing registration statements. In doing so, the company believes it will be in full compliance with this NASDAQ listing requirement ahead of the November 21 hearing. Finally, on October 15, the company received a waiver from Midcap Financial Trust as administrative agent for the lenders who are party to the Credit and Security Agreement, dated December 30, 2015, as amended, wherein the Lenders waived compliance with the company's obligation to deliver audited financial statements within 120 days of the company's year-end pursuant to the Credit Agreement. Upon filing of the 10-K today, the company delivered the required audited financial statements to Midcap, and the company is now in compliance with the Credit Agreement covenants.

05:04 EDT Nine FDA panel members voted to pursue withdrawal of Makena approval - AMAG Pharmaceuticals announced the Food and Drug Administration's Bone, Reproductive and Urologic Drugs Advisory Committee met to interpret the Prolong confirmatory clinical trial for Makena, a treatment approved to reduce preterm birth in pregnant women who have had a prior spontaneous preterm birth. "While the committee discussed multiple questions, in a mixed vote on the key question, nine advisory committee members voted to recommend that the FDA pursue withdrawal of approval for Makena and seven committee members voted to leave the product on the market under accelerated approval and require a new confirmatory trial," Amag said in a statement. Among the clinicians on the advisory committee, five of the six who practice obstetrics voted to keep Makena on the market and generate more data. Amag "agrees with several committee members who voiced concern that withdrawal of Makena would leave providers with no safe treatment options for pregnant women. The advisory committee's recommendation, while not binding, will be considered by the FDA in making its decision," the company added. "We are disappointed with the nearly split vote on this key question and we are committed to working with the FDA to identify feasible ways to generate additional efficacy data on Makena while retaining current access to the therapy for at-risk pregnant women," said Julie Krop, chief medical officer at Amag. "Preterm birth is an urgent public health crisis and the implications of leaving pregnant women and providers without access to therapy that is manufactured in a safe and regulated way is profoundly troubling. For more than a decade, healthcare providers have relied on hydroxyprogesterone caproate to reduce preterm delivery in high-risk patients, which aligns with recently updated treatment recommendations of the American College of Obstetricians and Gynecologists, as well as the Society for Maternal-Fetal Medicine."